Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 752 across all filing types
Latest filing 2026-04-30 Proxy Solicitation & In…
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Formularz pełnomocnictwa
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed proxy authorization form (pełnomocnictwo) for a company's Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie) scheduled for May 27, 2026. It includes instructions for the proxy, proposed resolutions to be voted on at the meeting, including capital increase through private subscription, changes to the company's statute, and changes in the supervisory board. The content is focused on shareholder voting instructions and meeting agenda items rather than financial results or management discussion. This type of document is typically classified as Proxy Solicitation & Information Statement (PSI), as it provides materials sent to shareholders to inform and solicit votes for the meeting.
2026-04-30 Polish
Projekty uchwał
AGM Information Classification · 95% confidence The document consists of multiple resolutions (uchwały) from an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie) of Medinice S.A. dated May 27, 2026. The resolutions cover topics such as the election of the chairman of the meeting, an increase in share capital through a private subscription of new shares (series O), amendments to the company's statute, determination of the number of supervisory board members, and changes in the supervisory board membership. These are typical contents of shareholder meeting resolutions. The document is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or voting results declaration but rather the actual resolutions passed at the meeting. Therefore, it fits best under AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting, including resolutions passed. The document length (over 10,000 characters) and detailed content confirm it is the meeting material itself, not just an announcement or summary.
2026-04-30 Polish
Ogłoszenie o zwołaniu NWZ
AGM Information Classification · 95% confidence The document is an announcement for an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie) of Medinice S.A. It includes details about the meeting date, agenda items such as capital increase through private subscription, changes in the supervisory board, and changes to the company statute. It also outlines procedures for participation, voting rights, and proxy information. There is no financial data or report content, but rather a formal notice to shareholders about the meeting and its agenda. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual or Extraordinary General Meeting. The document is lengthy (15,000 characters) and detailed, consistent with a meeting notice rather than a brief announcement or a report publication announcement. Therefore, the correct classification is AGM Information (AGM-R).
2026-04-30 Polish
Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia Medinice S.A. na dzień 27 maja 2026 r. - Content (EN)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a short announcement about convening an Extraordinary General Meeting (EGM), including details such as date, time, location, draft resolutions, proxy forms, and voting rights. It references a previous report and provides a link for more information. The document does not contain financial data or detailed reports but serves to inform shareholders about the meeting logistics and materials. Given the content and length (902 characters), this fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2026-04-30 English
Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia Medinice S.A. na dzień 27 maja 2026 r. - Content (PL)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about the convening of an Extraordinary General Meeting (EGM) of the company Medinice S.A., including the date, time, location, and agenda items such as draft resolutions and proxy forms. It references a previous report about the request to convene the meeting and provides logistical details for shareholders. This type of document is an announcement related to a shareholders' meeting, specifically the notice of the meeting and related materials, which fits the category of Proxy Solicitation & Information Statement (PSI). The document is short (859 characters) and contains the actual meeting notice and materials, not just a report publication announcement or a voting result. Therefore, the correct classification is PSI with high confidence.
2026-04-30 Polish
Zakończenie badania klinicznego wyrobu medycznego CoolCryo - Content (EN)
Regulatory Filings Classification · 85% confidence The document is a short announcement by the company’s Management Board informing investors of completion of a clinical investigation and the next steps toward regulatory conformity and CE marking. It is not an earnings release, financial report, M&A update, or any specialized disclosure such as dividends or director dealings. It is a general regulatory announcement about ongoing clinical and regulatory work. Therefore it falls under the fallback “Regulatory Filings” category (RNS).
2026-04-29 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.